Sophia Genetics
- Market cap
- 589.08M
- P/E (TTM)i
- -5.97
- P/Bi
- 7.09
- EPSi
- -1.17
- Div yieldi
- 0.00%
- 52W posi
- 61%
Anonymous reader poll. Unscientific, not investment advice.
About Sophia Genetics
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
- Founded
- 2011
- CEO
- Dr. Jurgi Camblong, M.B.A.,PhD
- Employees
- 415
- Headquarters
- Rolle, Vaud, Switzerland
- Fiscal year end
- 12-31
- Website
- sophiagenetics.com
Company profile
- Exchange
- US
- Symbol
- SOPH
- Market-cap rank
- #3618
- Listing date
- 2021-07-23
- Market cap
- 589.08M
- Float cap
- 452.40M
- Shares out
- 85.13M
- Float shares
- 65.38M
Sectors & themes
Quote time 2026-10-08 09:58:23 · For reference only, not investment advice and not tailored to your situation.